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Abstract: The Ca2+/calmodulin (CaM)-dependent protein kinase II (CaMKII) β has an essential function in dendritic
spines via binding to and reorganization of the actin cytoskeleton during plasticity events not shared by CaMKIIα
isoform. CaMKIIβ and CaMKIIα isoforms have remarkable structural differences within the variable region. Three
exons (E1, E3, and E4) are present in CaMKIIβ but not in CaMKIIα gene. Four splice variants of CaMKIIβ isoforms
(CaMKIIβ, β’, βe and β’e) were discovered in embryonic and adult brains. Exons E1 (lacked in βe and β’e) and E4
(lacked in β’ and β’e) are subject to differential alternative splicing. We hypothesized that the sequences encoded
by exons E1, E3, and/or E4 are involved in CaMKIIβ-specific bundling to the F-actin cytoskeleton. We tested the
colocalization and association of these CaMKIIβ variants within an F-actin-rich structure (microspike) in CaMKIIα
free embryonic day 18 (E-18) rat cortical neurons. Our results showed that CaMKIIβ and CaMKIIβ’ containing exon
E1 displayed an association with F-actin, while CaMKIIβe and CaMKIIβ’e lacking E1 did not. Moreover, CaMKIIβ’
lacking exon E4 but having E1 showed decreased actin bindingcapacity compared to WT CaMKIIβ. This suggested
E1 is required for the association between CaMKIIβ and F-actin, while E4 assists CaMKIIβ to associate with F-actin
better. Thus, alternative splicing of CaMKIIβ variants in developing neurons may serve as a developmental switch
for actin cytoskeleton-associated isoforms and therefore correlated with dendritic arborization and synapse formation during LTP.
Keywords: CaMKIIβ, F-actin, developing neuron, FRAP

Introduction
The plasticity of neuronal synapses is essential
for the formation and function of neural circuits, which is fundamental to learning and
memory. Long-term potentiation (LTP) of synaptic function is crucial for the process of learning
and memory by inducing the formation of new
dendritic spines and increasing the volume of
existing ones [1-4]. Calcium/calmodulin dependent protein kinase II (CaMKII) is a ubiquitously
expressed serine/threonine protein kinase
involved in a vast variety of cellular functions by
phosphorylating a number of substrates including several cytoskeletal and signaling proteins
[5-7]. Interestingly, CaMKII constitutes a substantial portion, 1-2%, of the total protein con-

tent of brain [8-11]. Especially in postsynaptic
density (PSD), the percentage of CaMKII goes
up to 10-30% [10]. It is much more abundant
than any other signal transduction molecules
and is comparable to the abundance of structural proteins found in the PSD, such as actin.
Correspondingly, in addition to its signaling
function, CaMKII also has a structural function
to bundle actin filaments in coupling structural
and functional plasticity of dendritic spines,
which plays a critical role in the molecular
mechanisms of LTP [12].
CaMKIIα and CaMKIIβ are the two major brain
isoforms where they make up the vast majority
of neuronal CaMKII [8]. CaMKIIβ was reported
to have specific morphogenic functions in regu-
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Figure 1. Schematic representation of individual isoforms of CaMKII variants. CaMKIIα and CaMKIIβ differ most in
the variable region (They are products of different genes and have minor differences in the kinase and association
domain which are not represented in this figure). Exon/intron structures of the CaMKIIα and β gene locus coding for
the variable regions are shown in bottom. The variable region of CaMKIIα contains only exon 2 (E2) and exon 5 (E5).
Both of these two exons are also presented in CaMKIIβ. Exon 3 (E3) is not identified in CaMKIIα but is contained in
all CaMKIIβ variants. In CaMKIIβ variants, WT CaMKIIβ has all five axons. CaMKIIβ’ contains exon 1 (E1), E2, E3 and
E5, but not exon E4. While CaMKIIβe lacks E1. E1 and E4 do not present in CaMKIIβ’e.

lating dendritic arborization and synapse density which are not shared by CaMKIIα isoform
[13]. This isoform specificity is very likely to be
mediated by the specific binding of CaMKIIβ,
but not CaMKIIα, to filamentous actin (F-actin)
[13, 14]. CaMKIIβ stabilizes the actin cytoskeleton in spines in a kinase activity independent
manner and thereby maintains the stability of
spine structure, while phosphorylation of
CaMKIIβ reduces this bundling activity [15-17].
The most remarkable structural difference
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between CaMKIIβ and CaMKIIα isoforms is
located within the variable region which connects the kinase domain and the association
domain [9, 18]. Three exons located in the variable region of CaMKIIβ, exon 1 (E1), exon 3
(E3), and exon 4 (E4), are not presented in the
CaMKIIα gene (Figure 1), which leads to the
speculation that sequences encoded by the
exons E1, E3, and/or E4 are involved in
CaMKIIβ-specific bundling to the F-actin cytoskeleton. In both embryonic and adult brains,

Int J Clin Exp Pathol 2014;7(6):2963-2975

CaMKIIβ and F-actin in developing neurons
four splice variants of CaMKIIβ isoforms are
detected: wildtype (WT) CaMKIIβ, CaMKIIβ’,
CaMKIIβe, and CaMKIIβ’e (a “e” refers to the
embryonic form) [19]. Exons E1 (lacked in βe
and β’e) and E4 (lacked in β’ and β’e) are subject to differential alternative splicing [18]. The
regulation of alternative splicing may control
the expression of actin-associated CaMKIIβ
variants differently, thereby possibly affects
the morphogenic functions of CaMKIIβ in dendritic arborization and/or synapse density.
To better understand the underlying mechanism, we investigated how CaMKIIβ variants
interact with F-actin in E-18 cortical neurons. In
previous study, a type of F-actin-rich structure
in cortical neurons from embryonic day 18
(E-18) rats was found and termed “Microspike”
by our group [16, 17]. Scanning electron microscopy results revealed that these microspikes
were composed of bundled actin filaments, and
confocal imaging showed that WT CaMKIIβ
strongly colocalized to this F-actin-rich structure. CaMKIIβ was found to be the only CaMKII
isoform enriched in microspikes in E-18 neocortex, where CaMKIIα was not detected until
postnatal day 7 (P7). Meanwhile, cortical neuron cultures expressed a detectable level of
CaMKIIβ at 4 days in vitro (DIV), while CaMKIIα
was not detected until 12 DIV [16, 17].
Therefore, this F-actin-rich structure, microspike, provides a powerful system in developing
neurons to further characterize the association
of CaMKIIβ and its variants with F-actin without
the disturbance of CaMKIIα isoform.
Materials and methods
Cell culture
Embryonic day 18 cortical neurons from pregnant Long Evans Rat were cultured as described
by Redmond et al. [20].
Dissection: Cortices of embryonic day 18
embryos were dissected from a sacrificed pregnant Long Evans rat (Charles River) and put in 1
× ice-cold Hanks Balanced Salt Solution (HBSS;
Invitrogen) while waiting for further treatment.
All cortices were incubated in enzyme solution
containing 10 units/ml of papain (Worthington
Biochemical Corp.) and 0.16 mg/ml of
L-cysteine (Sigma-Aldrich) for 40 minutes, the
enzymatic reaction was then stopped by trypsin inhibitor (Sigma).
Dissociation: Dissociation of cortical neurons
was proceeded within BF media containing
2965

Basal Medium Eagle (Invitrogen), 1 mM L-glutamine (Invitrogen), 1 × Penicillin Streptomycin
(Invitrogen), and 1% Fetal Bovine Serum (FBS;
Invitrogen). Then dissociated cortical neurons
were plated onto coverslips pre-coated by 20
μg/ml of poly-D-lysine (BD Biosciences) and 1
μg/ml of laminin (BD Biosciences). Cortical
neurons were maintained in BNF media containing BF and N2 supplement (Invitrogen) or
serum-free media (FSM) consisting of Neurobasal media (Invitrogen). After plated onto
plates or dishes, the cortical neurons were cultured in a humidified incubator at 37°C in a 5%
CO2 environment for 5 days in vitro (DIV). Cell
densities were 0.25 × 106 cells per well in 24
well plates for immunostaining and 0.75 × 106
cells per 35-mm glass-bottom dish (Mat Tek)
for live cell imaging.
DNA constructs
The green fluorescent protein (GFP)-tagged fulllength CaMKIIα, CaMKIIβ constructs (β, β’, βe,
β’e) and GFP-actin used in this study were
described by Lin et al. [16, 17].
Transfection
Cells were transfected with a modified calcium
phosphate transfection procedure as described
by Threadgill et al. [21]. Used culture medium
was removed and saved 1 hr prior to transfection and replaced with Dulbecco’s Modified
Eagle Medium (DMEM). The calcium phosphate/DNA precipitate was formed in HEPES
buffered saline (pH 7.07) for 15-20 min when
observed in light scattering. Then precipitate
was added dropwise to neurons in DMEM.
Following a 20-30 min transfection, during
which a fine sandy precipitate covered the neurons, the cultures were washed 3-4 times until
the precipitate disappeared in DMEM and then
returned to the saved original culture media.
Transfection efficiency via this method was typically between 1% and 5%, and there was no
apparent toxicity to the cells. As early as 12 hr
posttransfection the product of transfected
gene could be detected.
Immunoblotting
Respectively transfected cortical cultures were
harvested at 5 DIV with lysis buffer containing
TBS, 1% Triton X-100, 10% glycerol, 1-mM
PMSF, 1-μg/ml leupeptin, and 500-μM Na3VO4
on ice. Protein concentration was determined
Int J Clin Exp Pathol 2014;7(6):2963-2975
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Figure 2. Colocalization of CaMKIIβ variants with F-actin in microspikes. A. CaMKIIβ variants preferentially localized
to F-actin-rich structures: Confocal images of E-18 cortical neurons at 4 DIV with mGFP tagged CaMKIIβ variants
(green) and F-actin labeled with fluorescent conjugated phalloidin (red). Colocalization can be seen as yellow in the
merged images. B. Enrichment of GFP-tagged proteins as indicated in microspikes (ratio of microspike/soma mean
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intensity) *P < 0.05; ***P < 0.001; compared with GFP-actin. ##P < 0.01; ###P < 0.001; compared with CaMKIIβ.
@P < 0.05; compared with CaMKIIβ’. %P < 0.05; compared with CaMKIIβe. C. Microspikes-containing cells percentage of respectively transfected E-18 cortical neurons. **P < 0.01; ***P < 0.001; compared with GFP-actin. D.
Western blot analysis of E-18 cortical neuronal culture lysates 5 DIV after mGFP tagged CaMKIIβ variants transfection (upper panel). Endogenous CaMKIIβ were identified in cultured E-18 cortical neurons (lower panel).

by BCA assay. Of the total protein, 10 μg from
each was loaded onto SDS/PAGE and transferred to nitrocellulose. Blots were incubated in
blocking buffer as follows: 5% BSA in TBST
(0.1% Triton X-100) at 4°C overnight (CaMKIIβ,
1:1000). HRP-conjugated secondary antibodies were diluted in blocking buffer and visualized by chemiluminescence (Pierce).
Immunocytochemistry
Cultured cortical neurons were fixed with 4%
paraformaldehyde (PFA; J.T. Baker) and 4%
sucrose (Sigma-Aldrich) in 1 × phosphate buffer solution (PBS) for 15 min at room temperature at 5 DIV. Cultures were blocked with 3%
bovine serum albumin (BSA; Fisher), 0.3%
Triton X-100 (Sigma-Aldrich), 0.02% sodium
azide (Sigma-Aldrich) in PBS for 2 hr at room
temperature, then incubated with primary antibody GFP (1:1000; Molecular Probes), CaMKIIβ
(1:250; Zymed) at 4°C overnight. F-actin was
labeled with Alexa 488 or 568 conjugated phalloidin (1:25; Molecular Probes) to identify the
microspike structures. Cell nuclei were stained
with Hoechst. 25 × 75 mm glass micro slides
(VWR) were used to mount coverslips with
Aquamount (VWR) and sealed with fingernail
polish.
Images used to quantify microspike/soma ratio
were acquired from at least 3 independent
experiments by using an Axiovert200 Zeiss fluorescent microscope with 40 × (for cell counts)
or 63 × (for ratio measurement) objective. The
mean intensities of GFP in three randomly chosen microspikes from one cell and the soma
were measured and analyzed blind on GFP and
phalloidin labeled cells with Improvision software Openlab. The ratio was calculated by
(mean intensity in the microspike)/(mean intensity in the soma). The ratio values of three
microspikes were averaged to generate one
value per cell from 15-30 cells per construct.
Fluorescence recovery after photobleaching
(FRAP)
E18 cortical neurons were cultured on 35-mm
glass bottom dishes (MatTek) at 0.75 × 106
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cells/dish and imaged at 5 DIV. Before imaging,
media was replaced with Culture External Base
which containing 2-mM MgCl2, 2-mM CaCl2,
150-mM NaCl, 2.5-mM KCl, 10-mM glucose,
and 10-mM NaHEPES. Neurons were maintained in Culture External Base at room temperature during imaging for a maximum time of
two hours. Images were taken with a LSM510Meta Zeiss confocal microscope by using
63 × objective at 16 × zoom. Images were captured every 1 sec for 200 sec without any treatment or 500 s when cells were incubated with
10-μg/mlCytochalasinDfor30minor1-μMJasplakinolide for 1 hr before imaging to stabilize
actin filaments.
A circular region of interest (ROI) with radius of
0.43 μm was chosen for photobleaching.
Neurons were photobleached after 10 frames
of imaging with 10-12 iterations (20 iterations
for GFP alone) of maximal excitation power.
Background fluorescence, Fbkgd was determined in an unbleached area with similar initial
fluorescence as the bleached ROI. F(t)ROI was
normalized by background fluorescence with
an equation of F(t)norm = (F(t)ROI/Fbkgd. The
first time-point after the bleach was set to t = 0.
The normalized fluorescence of the frame
immediately before photobleaching, F(-1)norm,
was set as 1. The fluorescence at other time
points were normalized by F(-1)norm to generate the final fluorescence value, F(t)final = F(t)
norm/F(-1)norm. Final fluorescence was plotted over time to generate the fluorescence
recovery curve. When F(t)final reached 1, it was
considered to have complete recovery. The
50% recovery time was then determined by the
time required to reach 50% of final recovered
fluorescence, F1/2 = (F(∞)-F (0))/2.
Statistical analysis
Data on all parameters were expressed as
group mean ± SD. Differences between the
experimental groups were analyzed by using
the Student’s t-test. In all of the analyses,
results were considered statistically significant
when P < 0.05.
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Results
WT CaMKIIβ colocalized with the actin cytoskeleton stronger than the other variants
The mGFP fusion proteins of WT CaMKIIβ and
its splice variants CaMKIIβ’, CaMKIIβe and
CaMKIIβ’e were expressed in cultured E-18 cortical neurons. Confocal images were taken at 4
DIV to observe mGFP fusion proteins (green)
and fluorescent conjugated phalloidin (red)
labeled F-actin. Examples of transfected and
immunostained cortical neurons were shown in
Figure 2A. Colocalization can be seen as yellow
in the merged images.
No visible difference was observed between
WT CaMKIIβ and the splice variants CaMKIIβ’,
CaMKIIβe, and CaMKIIβ’e of their subcellular
localization. All the three splice variants were
observed mainly localized in the cytoplasm and
processes, and displayed highly enriched colocalization with microspikes like WT CaMKIIβ as
previously reported [16, 17]. No significant differences among their colocalization patterns
with microspikes in the E-18 cortical neurons
could be determined with naked eyes through
the microscope (Figure 2A).
To further quantitatively measure the F-actin
colocalization of CaMKIIβ variants, we examined their subcellular localization by determining the enrichment (ratio of microspike/soma
mean intensity) of these GFP-tagged variants in
microspikes (Figure 2B). The enrichment of WT
CaMKIIβ (2.03 ± 0.52) in microspikes was significantly higher than all the three variants, β’
(1.63 ± 0.46), βe (1.58 ± 0.27) and β’e (1.34 ±
0.30). The enrichment of WT CaMKIIβ in microspikes happened where F-actin was enriched,
indicated strong colocalization of WT CaMKIIβ
with F-actin and suggested a specific interaction between them. Although CaMKIIβ’,
CaMKIIβe and CaMKIIβ’e were also localized to
microspikes, they were significantly less
enriched in the microspikes than WT CaMKIIβ.
Among all the three variants, CaMKIIβ’e showed
the lowest colocalization ratio with F-actinbased-structure microspikes which close to the
non-binding GFP control (data not shown), indicating that CaMKIIβ’e had a very limited binding
capacity with F-actin. Together, these data indicated that WT CaMKIIβ had the strongest association with actin, whereas CaMKIIβ’e had the
weakest.
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Our previous results showed that the binding
ability of CaMKIIβ to F-actin was important for
the formation and maintenance of microspikes
[16]. To establish whether alternative splicing
of CaMKIIβ affects microspikes formation or
stability, we investigated the prevalence of the
microspikes in CaMKIIβ variants transfected
E-18 cortical neurons by calculating the percentage of microspike-containing cells. Our
results showed that 28.7 ± 5.0% WT CaMKIIβ
transfected neurons contained microspikes,
which was significantly less compared to the
40.3 ± 4.8% of GFP-actin control transfected
neurons (P < 0.05). However, no statistical significance was observed among the percentages of cells contained microspikes of WT
CaMKIIβ and the other splice variants, β’ (25.1
± 7.3%), βe (26.9 ± 3.6%) and β’e (24.0 ± 6.6%),
although β had the highest percentage of
microspike-containing cells than all the three
variants (Figure 2C). Noticeablely, endogenous
CaMKIIβ was co-expressed with the transfected GFP tagged CaMKIIβ variants in E-18 cortical neurons (Figure 2D), thus the ability of
endogenous CaMKIIβ binding to F-actin might
affect the number of microspikes-containing
cells and resulted in no significant difference
between all CaMKIIβ variants.
CaMKIIβ variants were less mobile within E-18
cortical neurons than CaMKIIα
Fluorescence recovery after photobleaching
(FRAP) analysis technology was employed to
further investigate the strength and dynamics
of CaMKIIβ splice variants and actin interaction
specifically in the microspikes of live E-18 cortical neurons. A randomly selected single microspike from each E-18 cortical neuron transfected with mGFP fusion CaMKIIβ variants was
photobleached at 5 DIV. The microspikes in
neurons transfected with CaMKIIα and GFPactin served as controls. Live cell images at 1
sec before bleach (-1 sec), bleach (0 sec), and
1, 5 and 30 sec after bleach (+ 1 sec, + 5 sec
and + 30 sec, respectively) were chosen to represent the FRAP process (Figure 3A).
Quantitative estimates of the association and
dissociation rates of binding can be obtained
from the FRAP [22-25].
The recorded intensities at each time point
were calculated as described in methods and
pulled together to generate the recovery curve
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which reflected the molecular diffusion and
binding dynamics. The recovery curve (Figure
3B) demonstrated that the recovery of
CaMKIIβ’, CaMKIIβe and CaMKIIβ’e were barely
distinguishable from each other but were
noticeably faster than WT CaMKIIβ. It was also
found that the GFP-actin control group regained
full recovery much slower than all the CaMKIIβ
variants, and the non-binding CaMKIIα control
showed the fastest recovery than all the other
groups.
Each group’s 50% recovery time was then calculated to further assess the recovery efficiency of each variants as well as controls (Figure
3C). Among all groups, GFP-actin control presented a standard level of how the actin fluorescence intensity recovered in this F-actin-rich
structure. The 50% recovery time of CaMKIIα
(5.62 ± 1.74 sec) was significant longer (P <
0.001) than all the CaMKIIβ variants and
CaMKIIβ. CaMKIIα was the fastest to regain
50% recovery of its original fluorescence intensity at 0.96 ± 0.41 sec. This is consistent with
previous reports that CaMKIIα did not directly
bind to F-actin [15, 16, 26, 27] and consequently more mobile than all CaMKIIβ variants
within the E-18 cortical neurons. The 50%
recovery time of WT CaMKIIβ (2.52 ± 1.09 sec)
was almost two and half folds longer than nonbinding CaMKIIα, indicating that the mobility of
WT CaMKIIβ was restricted by binding to F-acin
within the microspikes as reported [16, 17].
The extended 50% recovery time in WT CaMKIIβ
was revealed compared with variant CaMKIIβ’
(2.03 ± 0.77 sec), CaMKIIβe (1.75 ± 0.84 sec)
and CaMKIIβ’e (1.50 ± 0.68 sec). Statistical significances were identified between CaMKIIβ
and CaMKIIβe (P < 0.01), CaMKIIβ and
CaMKIIβ’e (P < 0.01). CaMKIIβ’ did not present
any significant difference in 50% recovery time
compare to CaMKIIβe and CaMKIIβ’e, although
its 50% recovery time was longer. The slower
recovery after photobleaching suggested the
presence of a binding partner restricted the
mobility of CaMKIIβ variants or controls. These
results suggested that all CaMKIIβ variants displayed a stronger binding ability with F-actin
than CaMKIIα, although not as strong as that of
WT CaMKIIβ.
CaMKIIβ presented stronger association with
immobilized F-actin than all other variants
The continuous dynamic of both CaMKIIβ and
actin existed in live E-18 cortical neurons
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makes it complicated to understand the interactions between them. Two drugs, Cytochalasin
D and Jasplakinolide, were introduced to the
system to inhibit actin movement. Cytochalasin
D was reported to notably slow down but not
completely prevent the recovery of actin,
whereas Jasplakinolide completely immobilized
actin, preventing any recovery of actin from
photobleaching [16, 28]. With the immobilized
actin within live E-18 cortical neurons, it is easier to explore as well as interpret the FRAP
results of the CaMKIIβ variants, which may
have potential interactions with actin.
We sorted the Cytochalasin D or Jasplakinolide
treated FRAP results of CaMKIIβ variants data
together to build respective recovery curves
(Figure 3D and 3F), and calculated their 50%
recovery time (Figure 3E-G). GFP-actin group
under respective drug treatments was set up
as standard control for actin recovery rates. It
presented significantly slower recovery compared to all CaMKIIβ variants groups with either
Cytochalasin D or Jasplakinolide treatment,
which strongly indicated that there was significant pool of CaMKIIβ variants which was not
bound with the immobilized actin and remained
mobile within the live cells. Because under
either Cytochalasin D or Jasplakinolide, GFPactins never regained their 50% recovery, no
50% recovery time result was shown for actin
group in Figure 3E and 3G. CaMKIIβe and β’e
recovery curves remained the same with either
Cytochalisin D or Jasplakinolide treatment, and
their 50% recovery time were significantly
shorter compared to drug treated WT CaMKIIβ
and CaMKIIβ’. These results indicated that the
association of WT CaMKIIβ and CaMKIIβ’ with
the F-actin were stronger than those of
CaMKIIβe and CaMKIIβ’e. The FRAP recovery
curve of WT CaMKIIβ and CaMKIIβ’ (Figure 3F)
were separated with Jasplakionlide treatment
but not with non-treatment nor with Cytochalisin
D treatment (Figure 3B). Moreover, the 50%
recovery time of WT CaMKIIβ (8.13 ± 3.09 sec)
was almost one fold extended than CaMKIIβ’
(5.12 ± 1.74 sec) (Figure 3G), suggested that
WT CaMKIIβ had stronger binding with F-actin
than CaMKIIβ’.
WT CaMKIIβ displayed slower recovery with
either Cytochalasin D or Jasplakinolide (Figure
4A), suggesting that it had strong binding with
F-actin and hence took longer time for the
bound ones to disassociate from the immobiInt J Clin Exp Pathol 2014;7(6):2963-2975
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Figure 3. FRAP results Recovery patterns of GFP-CaMKIIβ variants, GFP-CaMKIIα and GFP-actin from photobleaching. A. Live confocal images of GFP-CaMKIIβ variants transfected neuronsneuron before bleaching (-1 sec), at bleach time 0 sec, and + 1 sec, + 5 sec and + 30 sec after bleaching were shown as examples, as well
as control group GFP-CaMKIIα and GFP-actin. GFP tagged protein enriched areas can be seen as white pixels. Regions of interest (ROI) to be bleached were chosen
from fluorescently intense areas (marked with yellow dashed circles). B. Fluorescence recovery curves of GFP-CaMKIIα, GFP-CaMKIIβ, β’, βe and β’e and GFP-actin
without any treatment. C. Time required for the fluorescence of GFP-CaMKIIα, GFP-CaMKIIβ, β’, βe and β’e and GFP-actin to reache half-maximal recovery (50%
recovery time). D. Fluorescence recovery patterns of GFP-CaMKIIα, GFP-CaMKIIβ, β’, βe and β’e and GFP-actin with Cytochalasin D treatment. E. 50% Recovery
time of fluorescence of GFP-CaMKIIα, GFP-CaMKIIβ variants and GFP-actinafter Cytochalasin D treatment. F. Fluorescence recovery curves of GFP-CaMKIIα, GFPCaMKIIβ variants and GFP-actin with Jasplakinolide treatment. G. 50% Recovery time after Jasplakinolide treatment. ***p < 0.001; compared with GFP-actin. #P
< 0.05; ##P < 0.01; ###P < 0.001; compared with CaMKIIβ. @@P < 0.01; @@@P < 0.001; compared with CaMKIIβ’. %%P < 0.01; %%%P < 0.001; compared with
CaMKIIβe. &P < 0.05; &&&P < 0.001; compared with CaMKIIβ’e.
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Figure 4. Comparison of the effects with Cytochalasin D or Jasplakinolide treatment and without treatment in each GFP-CaMKIIβ variants groups, GFP-CaMKIIα and
FPG-actin group. Fluorescence recovery patterns under non-treatment, with Cytochalasin D and Jasplakinolide treatment of WT CaMKIIβ (A), CaMKIIβ’ (B), CaMKIIβe
(C) and CaMKIIβ’e (D), GFP-CaMKIIα (E) and GFP-actin (F). The recovery curves are shown on the left panels and the 50% recovery time plots are illustrated on the
right. ***P < 0.001; compared with non-treatment. ##P < 0.01; ###P < 0.001; compared with under Cytochalasin D treatment.
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lized actin. CaMKIIβ’ also displayed similar
results (Figure 4B), although not as significant
as WT CaMKIIβ. CaMKIIβe and CaMKIIβ’e did
not show a difference between Jasplakinolide
treatment and non-treatment control (Figure
4C and 4D). Jasplakinolide was reported to
completely immobilize the actin [28, 29], and
our GFP-actin with Jasplakinolide treatment
also displayed the same result as the actin did
not recover at all (Figure 4E). The completely
immobilized F-acin did not affect the recovery
of CaMKIIβe and CaMKIIβ’e, which indicated
that these two variants did not bind to F-actin,
otherwise delayed recovery curve and extended 50% recovery time would be noticed, as discovered in WT CaMKIIβ and CaMKIIβ’. GFPactin control displayed different recovery
patterns for actin under Cytochalasin D or
Jasplakinolide treatment (Figure 4F) which was
consistent with previous reports [16, 28], and
this might be responsible for the differences
between Cytochalasin D and Jasplakinolide in
most groups. Not surprisingly, non-binding control CaMKIIα also showed remarkable slow
recovery curve when treated with Jasplakinolide
(Figure 4E) as similar results were reported
[16].
Discussion
Some previous studies examined F-actin and
CaMKIIβ interactions in nonneuronal cells or in
dendrite spines where endogenous CaMKIIα
and CaMKIIβ were both expressed [13-15, 27].
F-actin was found to form thick bundled structures in vitro in the presence of the β-subunit of
CaMKII but not in the presence of the α-subunit
[15-17, 27, 30]. Protein structural studies indicate that CaMKII is an oligomer composed of
10-14 monomers arranged in rotational symmetry [31]. The CaMKIIα and β subunits coexist
in neurons can associate and form heterooligomers, which may bind simultaneously to
different actin filaments through multiple
β-subunits and, thus may confer on CaMKII
with the ability to bundle actin filaments together. In addition, CaMKIIα was addressed to have
negative effect on CaMKIIβ and F-actin association [16], and therefore might affect the related binding outcomes. In this study, we performed in vivo analyses of dynamic molecular
interactions in rat E-18 cortical neurons to
explore how alternative splicing in the variable
domain of CaMKIIβ affects the actin colocaliza-
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tion and association capability of CaMKIIβ variants in “microspikes”, a specific F-actin-rich
structure previously identified and termed by
our group [16, 17]. CaMKIIα was not expressed
at the age examined, while CaMKIIβ strongly
colocalized with F-actin within microspikes in
E-18 cortical neurons [16]. Therefore, potential
interactions between endogenous CaMKIIα
and CaMKIIβ variants were eliminated and we
can further explore the possible structural,
rather than enzymatic, role of CaMKIIβ variants
and their interactions with actin in developing
neurons without the disturbance of CaMKIIα.
WT CaMKIIβ contains the exons E1, E3 and E4
in its variable domain that CaMKIIα isoform
doesn’t have. Correspondingly, WT CaMKIIβ but
not CaMKIIα was proved to bind to F-actin [16].
Meanwhile, with the alternative splicing of
exons E1 and E4 in the variable region, three
CaMKIIβ variants, CaMKIIβ’, CaMKIIβe and
CaMKIIβ’e, were produced in addition to WT
CaMKIIβ [19]. The alternative splicing of
CaMKIIβ mRNA is developmentally regulated
and there appears to be a switch from the
embryonic isoforms to the adult isoforms. In rat
cortical neurons, CaMKIIβ and CaMKIIβ’ are
the major expressed adult isoforms. CaMKIIβe
and CaMKIIβ’e are embryonic isoforms
expressed at high levels from birth until postnatal day 4 (P4) [19, 32, 33]. Notably, each of the
new isoforms displayed identical protein kinase
activity characteristic of WT CaMKIIβ (showed
normal Ca2+/calmodulin-dependent phosphorylation of the specific CaMKII kinase) [19].
However, their kinase independent actin binding ability [16] had not been explored in cortical
neurons yet. We hypothesized that alternative
splicing of exons E1, E3 and/or E4 may be necessary and serve as a developmental switch for
the isoform-specific binding ability with F-actin,
which plays an essential role in the process of
neuronal maturation. Therefore, WT CaMKIIβ
(contains E1, E3 and E4), CaMKIIβ’ (contains
E1 and E3), CaMKIIβe (contains E3 and E4) as
well as CaMKIIβ’e (contains E3 only) were investigated for their colocalization and association
with microspikes in E-18 cortical neurons to
determine the effect of alternative splicing in
variable domain exons on their F-actin binding
ability.
The measurement of CaMKIIβ varaints’ colocalization with actin allowed us to evaluate the
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respective binding ability in the fixed cells
where both CaMKIIβ variants and actin were
immobilized. In this condition, the intensity of
colocalization should be consistent with the
corresponding F-actin binding ability. The stronger colocalization represents the stronger binding with F-actin. Both variants WT CaMKIIβ and
CaMKIIβ’ containing E1 presented higher colocalization ratios than the other two non-E1 variants CaMKIIβe and CaMKIIβ’e, indicating that
E1 is essential for CaMKIIβ association with
F-actin. The FRAP performed in live neurons
allowed us to explore the interactions between
CaMKIIβ variants and F-actin where both of
them are dynamic. Furthermore, immobilization
actin with drugs (Cytochalasin D or Jasplakinolide) helped us better understand the relative mobility and transferability of CaMKIIβ variants. If a molecule has a strong association
with F-actin, it will take longer time for the
bound ones to disassociate from the immobilized actin after the diffusion of limited free
molecules. Consistent with the colocalization
data, the significantly slowed recovery of WT
CaMKIIβ and CaMKIIβ’ after the drug treatment
indicates that exon E1 is responsible for the
significant pool of remained persistently bound
to the immobilized F-actin.
We noticed that all alternative splicing CaMKIIβ
variants contain E3 yet they displayed significant enrichment differences within the microspikes. Besides, CaMKIIβ’e, which contains
only E3, showed the lowest enrichment within
F-actin rich microspikes. It suggested that possessing E3 alone was not enough for the association of CaMKIIβ variants with F-actin. The
same conclusion can be drawn from the FRAP
results of CaMKIIβ’e which showed a significantly faster recovery than CaMKIIβ’ (containing E1 and E3) under either Cytochalasin D or
Jasplakinolide treatment.
CaMKIIβe, the dominant splice variant before
birth [19], contains E4 in addition to E3. However, no significant difference of colocalization
with microspikes was identified between CaMKIIβe and CaMKIIβ’e. FRAP recovery curves of
CaMKIIβe and CaMKIIβ’e were almost identical
to each other under all circumstances and no
significant difference was observed for 50%
recovery time between these two variants.
These data indicated that E4 may not be sufficient enough to target CaMKIIβe to F-actin
either. However, CaMKIIβ’, which only lacks E4
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compare to WT CaMKIIβ, showed decreased
colocalization within the microspikes, as well
as faster FRAP recovery curve and significantly
shorter 50% recovery time in most circumstances. These data referred that CaMKIIβ’ has
decreased binding ability compared to WT
CaMKIIβ, which suggested that the co-existence of E1 and E4 was needed for CaMKIIβ to
better association with F-actin.
Interestingly, GFP-CaMKIIα also recovered
more slowly from immobilized F-actin with drug
treatments. Although we cannot rule out other
mechanisms that may influence CaMKIIα mobility, the slowed recovery of GFP-CaMKIIα from
immobilized F-actin is most likely due to
CaMKIIα hetero-oligomerization via its association domain with endogenous CaMKIIβ [34],
which was reported to co-assemble with nonactin binding isoforms and target such heteromeric holoenzymes to the actin cytoskeleton
[26]. Oligomerization of CaMKIIβ, whether
homo-oligomers or hetero-oligomers, is essential for actin binding, while monomeric CaMKIIβ
can not bind to F-actin [35]. In CaMKIIα/β hetero-oligomers, the existence of CaMKIIα would
decrease the ability of endogenous CaMKIIβ
binding with F-actin [16], whereas homo-oligomers CaMKIIβe and CaMKIIβ’e did not binding
to the F-actin, and did not affect the endogenous CaMKIIβ binding either. Therefore,
CaMKIIβe and CaMKIIβ’e displayed slower
recovery time than CaMKIIα.
Briefly, our results are consistent with a previous report performed on Cos 7 cells in vitro
[27]. These results together clearly indicated
that in the E-18 cortical neurons in the absence
of CaMKIIα, the variable region exon E1, which
is lacked in CaMKIIβe and CaMKIIβ’e, is necessary for localization of actin cytoskeleton within cells. CaMKIIβ’e containing only exon E3 in
the variable region had no binding ability with
F-actin. Meanwhile, since CaMKIIβe which contains exon E4 only was not able to bind to
F-actin, while the variant CaMKIIβ’ containing
E1 only showed a decreased actin binding ability compared to WT CaMKIIβ, suggesting that
E4 may help E1 better associate with F-actin.
The actin cytoskeleton is remarkably dynamic
and involved in many major cellular events such
as LTP related synaptic plasticity [36], which
may be differentially modulated via alternative
splice of CaMKII isoforms with different actin
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association abilities [12, 13, 15-17, 27]. Within
living cells, there exsits a dynamic equilibrium
between the monomeric form of globular-actin
(G-actin) and the filamentous form of F-actin. It
was reported that LTP could shift this F-actin/
G-actin equilibrium toward F-actin, suggesting
that modification of the F-actin/G-actin equilibrium was required to trigger the morphological
reorganization during LTP [4]. The resemblance
between the F-actin-rich microspikes we
explored in embryonic neurons and the new
F-actin complex formed at the dendritic spine
during LTP hints that these F-actin-rich cellular
structures also serve both as a scaffold for the
mechanical stability of spine structure and as a
major docking site for postsynaptic proteins
that directly and indirectly bind to F-actin as
reported [37, 38]. This mechanism may be
used to selectively captures the LTP-related
proteins synthesized in the cell body and transported into dendrites [12]. In consideration that
the binding ability of CaMKIIβ to F-actin was
essential in mediating and regulating this
F-actin-rich structure [16], The alternative splicing of CaMKIIβ variants in developing neurons
which lead to differences in actin binding ability
may serve as a developmental switch for actin
cytoskeleton-associated isoforms and therefore correlates with dendritic arborization and
synapse formation during LTP.
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